3. |
- Abad-Gurumeta, A., et al.
(författare)
-
A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade
- 2015
-
Ingår i: Anaesthesia. - : Wiley-Blackwell Publishing Inc.. - 0003-2409 .- 1365-2044. ; 70:12, s. 1441-1452
-
Forskningsöversikt (refereegranskat)abstract
- We reviewed systematically sugammadex vs neostigmine for reversing neuromuscular blockade. We included 17 randomised controlled trials with 1553 participants. Sugammadex reduced all signs of residual postoperative paralysis, relative risk (95% CI) 0.46 (0.29-0.71), p=0.0004 and minor respiratory events, relative risk (95% CI) 0.51 (0.32-0.80), p=0.0034. There was no difference in critical respiratory events, relative risk (95% CI) 0.13 (0.02-1.06), p=0.06. Sugammadex reduced drug-related side-effects, relative risk (95% CI) 0.72 (0.54-0.95), p=0.02. There was no difference in the rate of postoperative nausea or the rate of postoperative vomiting, relative risk (95% CI) 0.94 (0.79-1.13), p=0.53, and 0.87 (0.65-1.17), p=0.36 respectively.
|
|